Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 811-819, October 2009

In vivo monitoring of intranuclear p27kip1 protein expression in breast cancer cells during trastuzumab (Herceptin) therapy☆

  • Bart Cornelissen

      Affiliations

    • Division of Nuclear Medicine, University Health Network, Toronto, ON, Canada M5S 3E2
    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada M5S 3M2
    • MRC/CRUK Gray Institute for Radiation Oncology and Biology, Oxford University, OX3 7LJ Oxford, UK
    • Corresponding Author InformationCorresponding author. Gray Institute for Radiation Oncology and Biology, Radiobiology Research Institute, Churchill Hospital, Headington, OX3 7LJ Oxford, UK.
    • ,
  • Veerle Kersemans

      Affiliations

    • Division of Nuclear Medicine, University Health Network, Toronto, ON, Canada M5S 3E2
    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada M5S 3M2
    • ,
  • Kristin McLarty

      Affiliations

    • Division of Nuclear Medicine, University Health Network, Toronto, ON, Canada M5S 3E2
    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada M5S 3M2
    • ,
  • Lara Tran

      Affiliations

    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada M5S 3M2
    • ,
  • Katherine A. Vallis

      Affiliations

    • MRC/CRUK Gray Institute for Radiation Oncology and Biology, Oxford University, OX3 7LJ Oxford, UK
    • ,
  • Raymond M. Reilly

      Affiliations

    • Division of Nuclear Medicine, University Health Network, Toronto, ON, Canada M5S 3E2
    • Department of Medical Imaging, University of Toronto, Toronto, ON, Canada M5S 3E2
    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada M5S 3M2

Received 26 January 2009; received in revised form 28 April 2009; accepted 10 May 2009. published online 30 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported by grants from the Ontario Cancer Research Network (No. 03-NOV-0428 and 1 mm Cancer Challenge) with funds from the Province of Ontario.

PII: S0969-8051(09)00127-9

doi:10.1016/j.nucmedbio.2009.05.003

Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 811-819, October 2009

Article Tools

* Image Usage & Resolution